Edition:
United Kingdom

Edge Therapeutics Inc (EDGE.OQ)

EDGE.OQ on NASDAQ Stock Exchange Global Select Market

0.87USD
16 Aug 2018
Change (% chg)

$-0.02 (-1.90%)
Prev Close
$0.89
Open
$0.89
Day's High
$0.89
Day's Low
$0.87
Volume
609
Avg. Vol
119,939
52-wk High
$17.76
52-wk Low
$0.81

Chart for

About

Edge Therapeutics, Inc. is a clinical-stage biotechnology company that discovers, develops and seeks to commercialize hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening critical care conditions. The Company's initial product candidates target rare, acute, life-threat... (more)

Overall

Beta: --
Market Cap(Mil.): $340.91
Shares Outstanding(Mil.): 30.85
Dividend: --
Yield (%): --

Financials

  EDGE.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -1.57 -- --
ROI: -43.75 1.78 14.61
ROE: -48.11 3.28 16.33

BRIEF-Edge Therapeutics Reports Quarterly Loss Per Share $0.67

* EDGE THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

01 May 2018

BRIEF-Edge Therapeutics Announces Review Of Strategic Alternatives

* EDGE THERAPEUTICS ANNOUNCES REVIEW OF STRATEGIC ALTERNATIVES

30 Apr 2018

BRIEF-Edge Therapeutics Provides Update Following Interim Analysis

* EDGE THERAPEUTICS PROVIDES UPDATE FOLLOWING INTERIM ANALYSIS OF PHASE 3 NEWTON 2 STUDY OF EG-1962 IN ANEURYSMAL SUBARACHNOID HEMORRHAGE

28 Mar 2018

BRIEF-Edge Therapeutics Reports Qtrly Loss Per Share $0.45

* EDGE THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

01 Mar 2018

Earnings vs. Estimates